Update on Secondary Cytoreduction in Recurrent Ovarian Cancer
Medscape,
Recurrent ovarian cancer is difficult to treat; it has high recurrence rates and poor targeted treatment options.
Recurrent ovarian cancer is difficult to treat; it has high recurrence rates and poor targeted treatment options.
Recurrent ovarian cancer is difficult to treat; is has high recurrence rates and poor targeted treatment options.
Recurrent ovarian cancer is difficult to treat; is has high recurrence rates and poor targeted treatment options.
In a phase 3 trial, combining cytoreductive surgery with chemotherapy significantly prolonged progression-free and overall…
In a phase 3 trial, combining cytoreductive surgery with chemotherapy significantly prolonged progression-free and overall…
Action Points Note that this study was published as an abstract and presented at a conference.